CD44 and neoplasm: Immunohistochemical (IHC) staining demonstrated that 5-methylcytosine (5mC) was down-regulated in subcutaneous tumor tissues from implantation models of CD133+/CD44+ shOPN compared with CD133+/CD44+ SCR.